DOW JONES27,081.36-879.44 -3.15%
S&P 5003,128.21-97.68 -3.03%
NASDAQ8,965.61-255.67 -2.77%

KalVista Pharma Reports Option Deal Between Co., Merck Related To Intravitreal Diabetic Macular Edema Candidate KVD001, Future Oral DME Molecules Has Expired

Benzinga · 02/10/2020 21:30